Current issue #16, 2018

Tatiana Golikova bound to work wonders in social sphere

The fact that Vladimir Putin was elected the President of Russia once again guarantees continuation of the external and internal policies pursued in his preceding presidential term. Therefore, it would seem that there is no room for shocks and sensations. However, apparently, the social sphere is set for sweeping changes. Premier Dmitry Medvedev nominated Tatiana Golikova as vice-presidential candidate for social issues. Most experts approved of this nomination. Mrs. Golikova is considered the right person for this position. Without her strong measures and cast-iron will, it would be very difficult for public health to achieve the goals specified in the President’s May Decree.

[PharmVestnik # 16, 15/05/2018, p. 1, cont’d p. 4]

// R&D – Pharma

CancerFund to support oncology R&D

Science is nearing its final battle with cancer. The latest scientific advances inspire hope as to a total victory over cancer, which will undoubtedly be one of the human greatest achievements. On the other hand, malignant tumors become increasingly widespread from year to year. If the negative trend prevails, they will come to dozens of millions in near future. Ways to reverse the situation were the focus of discussion at the starting conference of the Cancer Research Support Fund (CancerFund).

[PharmVestnik # 16, 15/05/2018, p. 2]

// Pharmacovigilance

Segregated liability to help decriminalize medical errors

The recent case of Dr. Misyurina has not only made people take sides with those standing for patients or those supporting doctors but has also made us see that the root causes of therapeutic failures are much more complex that negligent infliction of death or medical malpractice. At the same time, medical professionals themselves are not in a hurry to report adverse drug or medical device reactions to pharmacovigilance authorities. As a result, it is doctors that are made responsible for negative treatment outcomes. Now it is government officials that call on health providers not to assume full responsibility but share it with pharmaceutical manufacturers.

[PharmVestnik # 16, 15/05/2018, p. 6]

// Counterfeit Drugs

While Roscomnadzor¹ is after Telegram messenger, counterfeit drugs keep selling online

Increasingly often, people complain about defective medical devices and deplorable results of using cosmeceuticals. Thanks largely to the population complaints, for the first tome over the past 5 years, the Federal Service for ...